INS and type 2 diabetes mellitus: Additionally, four novel themes related to T2DM treatment emerged, including health locus of control for T2DM treatment [33, 34, 36, 37, 41, 43], insulin or injection-related burden [36, 37], medication-related hypoglycaemia [28, 34], and glucose meters [37].